The story of a cancer-fighting molecule that took half a century to build is really a story about how slow, stubborn ...

Adults in Germany are better than the international average at coping with problems in new and complex situations. However, this adaptive problem-solving skill depends more heavily on sociodemographic ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents-antibody-drug conjugates (ADCs)-can dramatically improve ...

In a recent study, mathematicians from Freie Universität Berlin have demonstrated that planar tiling, or tessellation, is much more than a way to create a pretty pattern. Consisting of a surface ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...

What if the toughest problems humanity faces—those that stump our brightest minds and stretch the limits of human ingenuity—could be tackled by a single, purpose-built system? Enter Gemini Deep Think, ...